PHAT Phathom Pharmaceuticals, Inc. - Common Stock
$9.67
价格 · 八月 19, 2026
截至...的财报数据 七月 30, 2026
52周区间
$8–$18
14% of range
分析师评级
BUY
17 analysts
目标价
$22
+122% upside
P/E (TTM)
-3.5
ROE
52.4%
净利润率
-126.4%
PHAT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$9.67
市值
$768M
P/E (TTM)
-3.5
每股收益 (TTM)
$-3.03
营收 (TTM)
$175M
股息收益率
—
ROE
52.4%
负债/权益
-0.5
52周区间
$8 – $18
PHAT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$175M
2022-12-31
→
2025-12-31
EPS
$-3.03
2021-12-31
→
2025-12-31
自由现金流
$-167M
2019-12-31
→
2025-12-31
利润率
-126.4%
2023-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
PHAT
同行中位数
P/E (TTM)
-3.5
11.7
P/S (TTM) (市销率 (TTM))
4.4
5.4
P/B (市净率)
-1.8
3.7
EV / EBITDA (企业价值 / EBITDA)
-5.3
—
Price / FCF (股价/自由现金流)
-4.6
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
PHAT
同行中位数
Gross Margin (毛利率)
87.1%
83.9%
Operating Margin (营业利润率)
-91.4%
—
Net Profit Margin (净利润率)
-126.4%
-45.6%
ROA
-69.4%
-25.4%
ROE
52.4%
-27.1%
ROIC
69.8%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
PHAT
同行中位数
Debt / Equity (负债/股东权益比率)
-0.5
—
Current Ratio (流动比率)
1.7
4.6
Quick Ratio (速动比率)
1.6
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
PHAT
同行中位数
Revenue YoY (营收同比增长)
216.9%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
PHAT
同行中位数
PHAT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
17 位分析师
- 强烈买入 6 35.3%
- 买入 9 52.9%
- 持有 2 11.8%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
10 位分析师 · 2026-08-18
中位数
$21.50
← 低于所有目标
$9.67
最低
$13.00
最高
$29.00
中位数目标
$21.50
+122.3%
平均目标
$21.50
+122.3%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.02%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.21 | $-0.26 | 0.05% |
| 2026年3月31日 | $-0.37 | $-0.33 | -0.04% |
| 2025年12月31日 | $-0.29 | $-0.39 | 0.10% |
| 2025年9月30日 | $-0.41 | $-0.56 | 0.15% |
| 2025年6月30日 | $-1.05 | $-1.06 | 0.01% |
| 2025年3月31日 | $-1.31 | $-1.17 | -0.14% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| SGP | — | — | — | — | 50.0% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $175M | $55M | $682.0K | $0 | |
| Cost of Revenue | $23M | $8M | $167.0K | $0 | |
| Gross Profit | $153M | $47M | $515.0K | $0 | |
| R&D Expense | $33M | $34M | $50M | $71M | |
| SG&A Expense | $280M | $291M | $118M | $101M | |
| Operating Expenses | $312M | $325M | $168M | $172M | |
| Operating Income | $-160M | $-277M | $-167M | $-172M | |
| Interest Expense | · | · | $42M | $27M | |
| Interest Income | $7M | $15M | $8M | $2M | |
| Other Non-op | $-190.0K | $-8.0K | $-188.0K | $-110.0K | |
| Pretax Income | $-221M | $-334M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-221M | $-334M | $-202M | $-198M | |
| EPS (Basic) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| EPS (Diluted) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| Shares (Basic) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| Shares (Diluted) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| EBITDA | $-159M | $-277M | $-167M | $-172M |
资产负债表 24
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $130M | $297M | $381M | $155M | |
| Receivables | $78M | $39M | $2M | $0 | |
| Inventory | $6M | $3M | $1M | $0 | |
| Prepaid Expense | $15M | $21M | $13M | $5M | |
| Current Assets | $229M | $360M | $397M | $161M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | |
| Other Non-current Assets | $3M | $2M | $2M | $299.0K | |
| Total Assets | $259M | $378M | $414M | $165M | |
| Accounts Payable | $5M | $11M | $13M | $10M | |
| Accrued Liabilities | $90M | $53M | $17M | $15M | |
| Current Liabilities | $132M | $86M | $39M | $26M | |
| Capital Leases | $2M | · | $462.0K | $1M | |
| Other Non-current Liabilities | $4M | $12M | $10M | $8M | |
| Total Liabilities | $697M | $632M | $487M | $240M | |
| Long-term Debt | $209M | $201M | $138M | $95M | |
| Total Debt | $209M | $201M | $138M | $95M | |
| Common Stock | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-1.48B | $-1.26B | $-929M | $-727M | |
| Treasury Stock | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-438M | $-254M | $-73M | $-75M | |
| Liabilities + Equity | $259M | $378M | $414M | $165M | |
| Shares Outstanding | 71,419,025 | 68,518,238 | 57,970,044 | 41,468,871 |
现金流 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $633.0K | $795.0K | $575.0K | $620.0K | |
| Stock-based Comp | $29M | $24M | $45M | $24M | |
| Other Non-cash | $25M | $43M | $18M | $26M | |
| Operating Cash Flow | $-167M | $-267M | $-138M | $-147M | |
| CapEx | $229.0K | $135.0K | $2M | $1M | |
| Investing Cash Flow | $-229.0K | $-135.0K | $-2M | $-1M | |
| Debt Issued | $0 | $59M | $39M | $0 | |
| Net Debt Issued | $0 | $59M | $39M | · | |
| Stock Issued | · | · | $14M | · | |
| Financing Cash Flow | $-288.0K | $183M | $368M | $120M | |
| Net Change in Cash | $-167M | $-84M | $228M | $-28M | |
| Free Cash Flow | $-167M | $-267M | $-139M | $-148M |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 87.1% | 85.6% | 75.5% | · | |
| Operating Margin | -91.4% | -502.2% | -24532.5% | · | |
| Net Margin | -126.4% | -605.1% | -29558.9% | · | |
| Pretax Margin | -126.4% | · | · | · | |
| EBITDA Margin | -91.0% | -500.8% | -24448.2% | · | |
| ROA | -69.4% | -84.4% | -69.7% | -111.6% | |
| ROE | 52.4% | 151.7% | 445.4% | 390.6% | |
| ROIC | 69.8% | · | · | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 4.2 | 10.2 | 6.1 | |
| Quick Ratio | 1.6 | 3.9 | 9.9 | 5.9 | |
| Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| LT Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| Interest Coverage | · | · | -4.0 | -6.3 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | · | |
| Inventory Turnover | 5.2 | 3.6 | 0.3 | · | |
| Receivables Turnover | 3.0 | 2.7 | 0.8 | · |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 216.9% | 8001.5% | · | · |
估值 (TTM) 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $175M | $55M | $682.0K | $0 | |
| Net Income TTM | $-221M | $-334M | $-202M | $-198M | |
| Market Cap | $1.18B | $471M | $529M | $465M | |
| Enterprise Value | $1.26B | $375M | $286M | $405M | |
| P/E | -5.5 | -1.5 | -2.3 | -2.2 | |
| P/S | 6.8 | 8.5 | 776.1 | · | |
| P/B | -2.7 | -1.9 | -7.3 | -6.2 | |
| P / Cash Flow | -7.1 | -1.8 | -3.8 | -3.2 | |
| P / FCF | -7.1 | -1.8 | -3.8 | -3.2 | |
| EV / EBITDA | -7.9 | -1.4 | -1.7 | -2.4 | |
| EV / FCF | -7.6 | -1.4 | -2.1 | -2.7 | |
| EV / Revenue | 7.2 | 6.8 | 418.9 | · | |
| Earnings Yield | -18.3% | -65.1% | -43.0% | -45.0% |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $74M | $58M | $58M | $50M | $40M | $29M | $30M | $16M | $7M | $2M | $682.0K | $0 | $0 | $0 | |
| Cost of Revenue | $15M | $12M | $8M | $6M | $5M | $4M | $4M | $2M | $1M | $426.0K | $167.0K | $0 | $0 | $0 | |
| Gross Profit | $59M | $46M | $50M | $43M | $34M | $25M | $26M | $14M | $6M | $1M | $515.0K | $0 | $0 | $0 | |
| R&D Expense | $8M | $8M | $7M | $7M | $9M | $9M | $9M | $9M | $7M | $9M | $13M | $12M | $13M | $11M | |
| SG&A Expense | $55M | $54M | $48M | $52M | $85M | $94M | $77M | $76M | $76M | $62M | $57M | $23M | $19M | $19M | |
| Operating Expenses | $63M | $62M | $56M | $59M | $94M | $104M | $85M | $85M | $83M | $71M | $70M | $36M | $32M | $30M | |
| Operating Income | $-4M | $-15M | $-6M | $-15M | $-60M | $-79M | $-59M | $-71M | $-77M | $-70M | $-70M | $-36M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | $18M | $17M | · | $10M | $10M | $9M | |
| Interest Income | $2M | $2M | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $348.0K | $1M | |
| Other Non-op | $-24.0K | $-831.0K | $-6.0K | $-7.0K | $-155.0K | $-22.0K | $49.0K | $-8.0K | $-6.0K | $-43.0K | $-14.0K | $-197.0K | $3.0K | $20.0K | |
| Net Income | $-18M | $-30M | $-21M | $-30M | $-76M | $-94M | $-74M | $-86M | $-91M | $-83M | $-80M | $-43M | $-41M | $-38M | |
| EPS (Basic) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| EPS (Diluted) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| Shares (Basic) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| Shares (Diluted) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| EBITDA | $-4M | $-15M | · | $-15M | $-60M | $-79M | · | $-71M | $-77M | $-70M | · | $-36M | $-32M | $-30M |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $181M | $130M | $135M | $150M | $212M | $297M | $335M | $276M | $322M | $381M | $214M | $249M | $130M | |
| Receivables | $97M | $81M | $78M | $56M | $51M | $36M | $39M | $21M | $11M | $4M | $2M | · | · | · | |
| Inventory | $8M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $1M | $111.0K | $111.0K | · | |
| Prepaid Expense | $8M | $8M | $15M | $13M | $15M | $13M | $21M | $15M | $15M | $13M | $13M | $13M | $9M | $10M | |
| Current Assets | $296M | $277M | $229M | $208M | $219M | $265M | $360M | $374M | $305M | $340M | $397M | $227M | $258M | $140M | |
| PP&E (Net) | $971.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | $5M | · | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $299.0K | |
| Total Assets | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Accounts Payable | $5M | $6M | $5M | $1M | $4M | $12M | $11M | $7M | $8M | $8M | $13M | $6M | $4M | $5M | |
| Accrued Liabilities | $109M | $83M | $90M | $65M | $64M | $43M | $53M | $36M | $27M | $17M | $17M | $13M | $15M | $8M | |
| Current Liabilities | $154M | $125M | $132M | $93M | $92M | $74M | $86M | $65M | $47M | $43M | $39M | $24M | $22M | $14M | |
| Capital Leases | $2M | $2M | $2M | $2M | $589.0K | $0 | · | $0 | $133.0K | $292.0K | $462.0K | $628.0K | $789.0K | $945.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $12M | $12M | $12M | $12M | $11M | $10M | $10M | $10M | $8M | $8M | $8M | |
| Total Liabilities | $671M | $642M | $697M | $663M | $656M | $633M | $632M | $574M | $553M | $505M | $487M | $255M | $247M | $234M | |
| Long-term Debt | $165M | $164M | $209M | $207M | $205M | $203M | $201M | $176M | $174M | $149M | $138M | $99M | $98M | $97M | |
| Total Debt | $165M | $164M | · | $207M | $205M | $203M | · | $176M | $174M | $149M | · | $99M | $98M | $97M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.53B | $-1.51B | $-1.48B | $-1.46B | $-1.43B | $-1.36B | $-1.26B | $-1.19B | $-1.10B | $-1.01B | $-929M | $-849M | $-806M | $-765M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-344M | $-337M | $-438M | $-423M | $-406M | $-338M | $-254M | $-187M | $-234M | $-149M | $-73M | $-18M | $18M | $-90M | |
| Liabilities + Equity | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Shares Outstanding | 80,070,048 | 79,442,367 | 71,419,025 | 71,043,149 | 70,104,419 | 69,638,070 | 68,518,238 | 68,323,938 | 58,601,025 | 58,524,101 | 57,970,044 | 56,809,085 | 56,639,085 | 43,571,140 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $110.0K | $128.0K | $156.0K | $172.0K | $177.0K | $193.0K | $191.0K | $197.0K | $214.0K | $185.0K | $121.0K | $123.0K | $146.0K | |
| Stock-based Comp | $7M | $6M | $6M | $9M | $8M | $6M | $7M | $6M | $6M | $6M | $25M | $6M | $7M | $7M | |
| Other Non-cash | · | $9M | · | · | · | $4M | · | · | · | $8M | · | · | · | $-9M | |
| Operating Cash Flow | $-2M | $-16M | $-5M | $-14M | $-63M | $-85M | $-63M | $-64M | $-71M | $-69M | $-44M | $-32M | $-22M | $-40M | |
| CapEx | $44.0K | $61.0K | $87.0K | $27.0K | $97.0K | $18.0K | $5.0K | $44.0K | $46.0K | $40.0K | $475.0K | $939.0K | $6.0K | $214.0K | |
| Investing Cash Flow | $-44.0K | $-61.0K | $-87.0K | $-27.0K | $-97.0K | $-18.0K | $-5.0K | $-44.0K | $-46.0K | $-40.0K | $-475.0K | $-939.0K | $-6.0K | $-214.0K | |
| Debt Issued | $0 | $173M | $0 | $0 | $0 | $0 | $25M | $0 | $25M | $10M | $39M | $0 | $0 | $0 | |
| Net Debt Issued | · | $-56M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $4M | $67M | $-97.0K | $-271.0K | $80.0K | $0 | $26M | $122M | $25M | $10M | $212M | $13.0K | $142M | $14M | |
| Net Change in Cash | $2M | $51M | $-5M | $-14M | $-63M | $-85M | $-37M | $58M | $-46M | $-59M | $168M | $-33M | $119M | $-26M | |
| Free Cash Flow | · | $-16M | · | · | · | $-85M | · | · | · | $-69M | · | · | · | $-40M |
盈利能力 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.7% | 79.4% | · | 87.5% | 87.2% | 86.9% | · | 85.6% | 81.2% | 77.7% | · | · | · | · | |
| Operating Margin | -5.3% | -26.6% | · | -30.9% | -151.7% | -276.5% | · | -433.0% | -1055.4% | -3658.7% | · | · | · | · | |
| Net Margin | -23.7% | -52.1% | · | -60.6% | -191.9% | -330.7% | · | -523.3% | -1248.6% | -4333.3% | · | · | · | · | |
| EBITDA Margin | -5.3% | -26.4% | · | -30.9% | -151.7% | -275.9% | · | -433.0% | -1055.4% | -3647.5% | · | · | · | · | |
| ROA | -6.1% | -10.1% | · | -9.6% | -26.6% | -29.0% | · | -27.4% | -31.3% | -33.1% | · | -19.7% | -17.1% | -25.8% | |
| ROE | 4.7% | 9.0% | · | 9.8% | 23.7% | 38.7% | · | 83.5% | 84.6% | 69.4% | · | 195.7% | -772.9% | 145.0% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.2 | · | 2.2 | 2.4 | 3.6 | · | 5.7 | 6.5 | 7.8 | · | 9.5 | 12.0 | 9.7 | |
| Quick Ratio | 1.8 | 2.1 | · | 2.1 | 2.2 | 3.4 | · | 5.4 | 6.1 | 7.5 | · | 8.9 | 11.6 | 9.0 | |
| Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| LT Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -4.4 | -4.1 | · | -3.5 | -3.3 | -3.3 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 2.7 | 2.5 | · | 1.8 | 1.8 | 1.6 | · | 1.5 | 1.2 | 0.6 | · | · | · | · | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.3 | 1.3 | 1.4 | · | 1.6 | 1.3 | 1.0 | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $222M | $176M | · | $134M | $92M | $54M | · | $26M | $9M | $2M | · | · | · | · | |
| Net Income TTM | $-154M | $-230M | · | $-286M | $-347M | $-354M | · | $-303M | $-259M | $-205M | · | $-173M | $-181M | $-180M | |
| Market Cap | $869M | $883M | · | $836M | $672M | $437M | · | $1.24B | $604M | $622M | · | $589M | $811M | $311M | |
| Enterprise Value | $851M | $865M | · | $908M | $728M | $428M | · | $1.08B | $502M | $448M | · | $475M | $660M | $278M | |
| P/E | -5.3 | -3.5 | · | -2.9 | -1.8 | -1.1 | · | -3.6 | -2.2 | -2.7 | · | -2.7 | -3.3 | -1.5 | |
| P/S | 3.9 | 5.0 | · | 6.2 | 7.3 | 8.1 | · | 48.3 | 65.4 | 325.1 | · | · | · | · | |
| P/B | -2.5 | -2.6 | · | -2.0 | -1.7 | -1.3 | · | -6.6 | -2.6 | -4.2 | · | -33.1 | 46.1 | -3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 46.1 | · | |
| P / Cash Flow | · | -56.4 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| P / FCF | · | -56.2 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| EV / EBITDA | -214.6 | -56.3 | · | -59.5 | -12.1 | -5.4 | · | -15.2 | -6.5 | -6.4 | · | -13.3 | -20.8 | -9.3 | |
| EV / FCF | · | -55.1 | · | · | · | -5.0 | · | · | · | -6.5 | · | · | · | -7.0 | |
| EV / Revenue | 3.8 | 4.9 | · | 6.8 | 7.9 | 7.9 | · | 42.1 | 54.3 | 234.5 | · | · | · | · | |
| Earnings Yield | -18.8% | -28.3% | · | -34.8% | -54.6% | -89.5% | · | -28.0% | -44.5% | -36.8% | · | -36.7% | -30.6% | -64.6% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $175M | $55M | $682.0K | $0 | — |
| 毛利率 % | 87.1% | 85.6% | 75.5% | — | — |
| 营业利润率 % | -91.4% | -502.2% | -24532.5% | — | — |
| 净收入 | $-221M | $-334M | $-202M | $-198M | $-144M |
| 稀释后每股收益 (EPS) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | -0.5 | -0.8 | -1.9 | -1.3 | 1.2 |
| 流动比率 | 1.7 | 4.2 | 10.2 | 6.1 | 9.9 |
| 速动比率 | 1.6 | 3.9 | 9.9 | 5.9 | 9.7 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-167M | $-267M | $-139M | $-148M | $-149M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 179 家申报者 · $617.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 33 (+1 与上一季度对比) | 30 (-5 与上一季度对比) | 51 (-22 与上一季度对比) | 50 (+13 与上一季度对比) | +3.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135261406 | 12466489 | 21.91% | 股份 |
| Medicxi Ventures Management (Jersey) Ltd | $80990606 | 7464572 | 13.12% | 股份 |
| Carlyle Group Inc. | $37940367 | 3496808 | 6.15% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $36627799 | 3375834 | 5.93% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $28827842 | 2656944 | 4.67% | 股份 |
| NEA Management Company, LLC | $21267834 | 1960169 | 3.44% | 股份 |
| 683 Capital Management, LLC | $20072501 | 1850000 | 3.25% | 股份 |
| STATE STREET CORP | $17211605 | 1586323 | 2.79% | 股份 |
| Catalys Pacific, LLC | $16208316 | 1493854 | 2.63% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15871000 | 1462738 | 2.57% | 股份 |
| GOLDMAN SACHS GROUP INC | $15552303 | 1433392 | 2.52% | 股份 |
| WASATCH ADVISORS LP | $14897577 | 1340916 | 2.41% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $12271034 | 1130751 | 1.99% | 股份 |
| Ensign Peak Advisors, Inc | $11413256 | 1051913 | 1.85% | 股份 |
| Propel Bio Management, LLC | $11396384 | 1050358 | 1.85% | 股份 |
| Point72 Asset Management, L.P. | $11090794 | 1022193 | 1.80% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8643446 | 796631 | 1.40% | 股份 |
| SummitTX Capital, L.P. | $8566618 | 789550 | 1.39% | 股份 |
| EcoR1 Capital, LLC | $6781250 | 625000 | 1.10% | 股份 |
| PERCEPTIVE ADVISORS LLC | $5772200 | 532000 | 0.93% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $5631975 | 519076 | 0.91% | 股份 |
| CITADEL ADVISORS LLC | $5216680 | 480800 | 0.84% | 买入期权 |
| VANGUARD GROUP INC | $4969501 | 299548 | 0.80% | 股份 |
| StepStone Group LP | $4689364 | 422085 | 0.76% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4547170 | 419094 | 0.74% | 股份 |
| Woodline Partners LP | $4004214 | 369052 | 0.65% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $3847117 | 354573 | 0.62% | 股份 |
| AMERIPRISE FINANCIAL INC | $3189358 | 293950 | 0.52% | 股份 |
| Simplify Asset Management Inc. | $2704547 | 249267 | 0.44% | 股份 |
| JPMORGAN CHASE & CO | $2616050 | 240667 | 0.42% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $2456440 | 226400 | 0.40% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2281755 | 210300 | 0.37% | 买入期权 |
| NewEdge Advisors, LLC | $2212988 | 203962 | 0.36% | 股份 |
| Avidity Partners Management LP | $2170000 | 200000 | 0.35% | 股份 |
| Jump Financial, LLC | $2081746 | 191866 | 0.34% | 股份 |
| Opaleye Management Inc. | $2013641 | 185589 | 0.33% | 股份 |
| CITADEL ADVISORS LLC | $2006176 | 184901 | 0.32% | 股份 |
| Trexquant Investment LP | $1886641 | 173884 | 0.31% | 股份 |
| Jones Hill Capital LP | $1752123 | 161486 | 0.28% | 股份 |
| MARSHALL WACE, LLP | $1751191 | 161400 | 0.28% | 股份 |
| XTX Topco Ltd | $1473777 | 135832 | 0.24% | 股份 |
| DIADEMA PARTNERS LP | $1409958 | 129950 | 0.23% | 股份 |
| SIG BROKERAGE, LP | $1345400 | 124000 | 0.22% | 买入期权 |
| Engineers Gate Manager LP | $1283088 | 118257 | 0.21% | 股份 |
| Virtus Investment Advisers, LLC | $1216708 | 112139 | 0.20% | 股份 |
| BANK OF AMERICA CORP /DE/ | $1178885 | 108653 | 0.19% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1105968 | 101745 | 0.18% | 股份 |
| JANE STREET GROUP, LLC | $1096761 | 101084 | 0.18% | 股份 |
| Stratos Wealth Partners, LTD. | $1085000 | 100000 | 0.18% | 股份 |
| Swiss National Bank | $1071980 | 98800 | 0.17% | 股份 |
| GILDER GAGNON HOWE & CO LLC | $956254 | 88134 | 0.15% | 股份 |
| Stonepine Capital Management, LLC | $922358 | 85010 | 0.15% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $838879 | 77316 | 0.14% | 股份 |
| JANE STREET GROUP, LLC | $837620 | 77200 | 0.14% | 买入期权 |
| BlackRock, Inc. | $835548 | 77009 | 0.14% | 股份 |
| Campbell & CO Investment Adviser LLC | $746035 | 68759 | 0.12% | 股份 |
| Penn Mutual Asset Management | $681402 | 62802 | 0.11% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $675771 | 62283 | 0.11% | 股份 |
| RHUMBLINE ADVISERS | $654740 | 60346 | 0.11% | 股份 |
| UBS Group AG | $635105 | 58535 | 0.10% | 股份 |
| Birchview Capital, LP | $596750 | 55000 | 0.10% | 股份 |
| D. E. Shaw & Co., Inc. | $585206 | 53936 | 0.09% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $547612 | 49290 | 0.09% | 股份 |
| CITIGROUP INC | $543661 | 50107 | 0.09% | 股份 |
| Bank of New York Mellon Corp | $540037 | 49773 | 0.09% | 股份 |
| Pale Fire Capital SE | $539386 | 49713 | 0.09% | 股份 |
| NOMURA HOLDINGS INC | $532735 | 49100 | 0.09% | 卖出期权 |
| Man Group plc | $528167 | 48679 | 0.09% | 股份 |
| AlphaQuest LLC | $468668 | 28250 | 0.08% | 股份 |
| ADAR1 Capital Management, LLC | $465465 | 42900 | 0.08% | 股份 |
| Quantbot Technologies LP | $463892 | 42755 | 0.08% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $459866 | 42384 | 0.07% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $446866 | 40222 | 0.07% | 股份 |
| BARCLAYS PLC | $435660 | 40153 | 0.07% | 股份 |
| NOMURA HOLDINGS INC | $434000 | 40000 | 0.07% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $432318 | 39845 | 0.07% | 股份 |
| Fiduciary Trust Co | $387681 | 35731 | 0.06% | 股份 |
| Nebula Research & Development LLC | $363816 | 37937 | 0.06% | 股份 |
| Persistent Asset Partners Ltd | $359753 | 33157 | 0.06% | 股份 |
| ALLSTATE CORP | $356694 | 32875 | 0.06% | 股份 |
| Squarepoint Ops LLC | $342806 | 31595 | 0.06% | 股份 |
| CITADEL ADVISORS LLC | $337435 | 31100 | 0.05% | 卖出期权 |
| VANGUARD ASSET MANAGEMENT, Ltd | $309290 | 28506 | 0.05% | 股份 |
| MetLife Investment Management, LLC | $304961 | 28107 | 0.05% | 股份 |
| Kera Capital Partners, Inc. | $291062 | 26826 | 0.05% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $280342 | 25838 | 0.05% | 股份 |
| Caption Management, LLC | $260400 | 24000 | 0.04% | 买入期权 |
| Caption Management, LLC | $260400 | 24000 | 0.04% | 卖出期权 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $245720 | 22647 | 0.04% | 股份 |
| COMMONWEALTH EQUITY SERVICES, LLC | $244500 | 22535 | 0.04% | 股份 |
| Summit Financial Wealth Advisors, LLC | $240252 | 22143 | 0.04% | 股份 |
| JANUS HENDERSON GROUP PLC | $239403 | 21500 | 0.04% | 股份 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $236198 | 18731 | 0.04% | 股份 |
| Vanguard Global Advisers, LLC | $225344 | 20769 | 0.04% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $220255 | 20300 | 0.04% | 卖出期权 |
| Invesco Ltd. | $211065 | 19453 | 0.03% | 股份 |
| INSPIRION WEALTH ADVISORS, LLC | $209794 | 19914 | 0.03% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $192316 | 17725 | 0.03% | 股份 |
| State of Wyoming | $191383 | 17639 | 0.03% | 股份 |
| PROFUND ADVISORS LLC | $187455 | 17277 | 0.03% | 股份 |
公司内部人士 20 位内幕人士 · 9 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Steven L Basta | President and CEO | 2026年2月10日 F | 373315 | 0 | 0 | $0 |
| Molly Henderson | CFO and CBO | 2025年4月7日 S | 89868 | 0 | 0 | $0 |
| Todd P. Branning | Chief Financial Officer | 2021年1月28日 A | — | 0 | 0 | $0 |
| Terrie Curran | President and Chief Executive | 2025年2月27日 A | 360465 | 0 | 0 | $0 |
| Azmi Nabulsi | Chief Operating Officer | 2025年2月27日 A | 312590 | 0 | 0 | $0 |
| Robert Charles Breedlove | Principal Accounting Officer | 2026年7月14日 F | 59925 | 0 | 2 | $-12652 |
| Anne Marie Cook | Chief Legal Off. & Corp. Sec. | 2026年2月10日 F | 88660 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial & Bus. Officer | 2026年1月2日 A | 226715 | 0 | 0 | $0 |
| Anthony J. Guzzo | VP, Chief Accounting Officer | 2022年1月19日 A | 8399 | 0 | 0 | $0 |
| Asit Parikh | 董事 | 2026年5月22日 G | 148500 | 0 | 0 | $0 |
| Mark Stenhouse | 董事 | 2026年5月19日 A | 54122 | 0 | 0 | $0 |
| Theodore R Schroeder | 董事 | 2026年5月19日 A | 45122 | 0 | 0 | $0 |
| James N. Topper | 董事 | 2026年5月19日 A | 66718 | 0 | 0 | $0 |
| Frank Karbe | 董事 | 2026年5月19日 A | 91622 | 0 | 0 | $0 |
| Michael F Cola | 董事 | 2026年5月19日 A | 63920 | 0 | 0 | $0 |
| Heidi Kunz | 董事 | 2026年5月19日 A | 54122 | 0 | 0 | $0 |
| David A Socks | 董事 | 2024年5月23日 A | 19500 | 0 | 0 | $0 |
| Tadataka Yamada | 董事 | 2021年5月21日 A | — | 0 | 0 | $0 |
| Jonathan S. Edwards | 董事 | 2019年10月29日 C | 47984 | 0 | 0 | $0 |
| Takeda Pharmaceutical Company Limited | — | 2024年1月24日 S | 3755583 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×3 申报 | 2025年11月4日 | 8.60% | 修订 | — | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×8 申报 | 2024年8月22日 | — | 初始申报 | 被动投资 | SEC |
| Takeda Pharmaceutical Company Limited ×3 申报 | 2024年4月10日 | — | 初始申报 | — | SEC |
| Frazier Life Sciences IX, L.P ., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes | 2023年5月26日 | — | 初始申报 | 被动投资 | SEC |
| S.S. OR ×5 申报 | 2021年11月12日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 34 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.23% | 64997 NS | 2026年4月30日 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.01% | 11659 NS | 2026年4月30日 | N-PORT |
| IHE · iShares Trust | 0.09% | 182732 SH | 2026年8月8日 | 每日 |
| IWC · iShares Trust | 0.09% | 166627 SH | 2026年8月8日 | 每日 |
| GSSC · Goldman Sachs ETF Trust | 0.05% | 49552 NS | 2026年5月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.05% | 4339 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.04% | 78352 SH | 2026年8月8日 | 每日 |
| BIB · ProShares Trust | 0.04% | 2912 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | 0.04% | 414853 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 283184 SH | 2026年8月8日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 30521 SH | 2026年8月8日 | 每日 |
| IWN · iShares Trust | 0.02% | 329427 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.02% | 20112 NS | 2026年4月30日 | N-PORT |
| ISCG · iShares Trust | 0.02% | 18573 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.01% | 1253335 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.01% | 2182 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 586438 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 15003 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 148237 SH | 2026年8月8日 | 每日 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 236650 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 21971 NS | 2026年4月30日 | N-PORT |
| ISCB · iShares Trust | 0.01% | 2641 SH | 2026年8月8日 | 每日 |
| IWO · iShares Trust | 0.01% | 129591 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.01% | 1707 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.00% | 1727 NS | 2026年5月31日 | N-PORT |
| WSML · iShares Trust | 0.00% | 2570 SH | 2026年8月8日 | 每日 |
| HDG · ProShares Trust | 0.00% | 43 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1333 NS | 2026年5月31日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 205 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 79259 SH | 2026年8月8日 | 每日 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 33490 NS | 2026年5月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 9288 SH | 2026年8月8日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2007668 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3478 SH | 2026年8月8日 | 每日 |